Home › Funds › Octagon Capital Advisors LP › GOSS
Octagon Capital Advisors LP position in GOSS
GOSSAMER BIO INC · Health Care
Octagon Capital Advisors LP reported holding 96,875 shares of GOSS (GOSSAMER BIO INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.15% of its reported portfolio and ranking #26 among its reported holdings. Octagon Capital Advisors LP has disclosed GOSS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's GOSS position evolved
Octagon Capital Advisors LP first disclosed a stake in GOSS in Q3 2023 at 8,187,883 shares (US$6.8M). The position peaked in Q3 2025 at 17,050,000 shares, worth US$44.8M. Across 13 filings, Octagon Capital Advisors LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 96,875 shares valued at US$1.1M — a reduction of -7,653,125 shares quarter over quarter.. Notable position changes include a 100% increase in Q4 2024 (shares rose 22% over the following quarter), a 44% trim in Q1 2026 (shares fell 50% over the following quarter), a 99% trim in Q3 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 8.19M | $6.82M | New |
| Q4 2023 | 9.19M | $8.38M | Add |
| Q1 2024 | 9.19M | $10.84M | Hold |
| Q2 2024 | 9.19M | $8.28M | Hold |
| Q3 2024 | 9.19M | $9.06M | Hold |
| Q4 2024 | 18.35M | $16.60M | Add |
| Q1 2025 | 18.35M | $20.18M | Hold |
| Q2 2025 | 18.35M | $22.57M | Hold |
| Q3 2025 | 17.05M | $44.84M | Reduce |
| Q4 2025 | 13.92M | $43.14M | Reduce |
| Q1 2026 | 7.75M | $2.55M | Reduce |
| Q2 2026 | 7.75M | $1.28M | Hold |
| Q3 2026 | 96.88K | $1.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GOSS and 13F data
GOSS (GOSSAMER BIO INC) is a Health Care company. 6 other funds we track also report a position in GOSS — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$11.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GOSS
- TANG CAPITAL MANAGEMENT LLC 17.84M sh · $11.16M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held GOSS?
Octagon Capital Advisors LP has disclosed GOSS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Octagon Capital Advisors LP's current position in GOSS?
As of Q3 2026, Octagon Capital Advisors LP holds 96.88K shares of GOSS (GOSSAMER BIO INC), valued at $1.15M, representing 0.15% of its reported portfolio and ranking #26.
Has Octagon Capital Advisors LP been buying or selling GOSS?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in GOSS. The position peaked in Q3 2025 at 17.05M shares.
Which other funds hold GOSS?
Other major institutional holders of GOSS include TANG CAPITAL MANAGEMENT LLC, among 6 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.